Lisinopril And Hydrochlorothiazide recalls

Lisinopril And Hydrochlorothiazide products have been recalled 5 times, most recently on 23 Jul 2025. The recalling company is usually Lupin Pharmaceuticals. The most common reason is manufacturing (cgmp) deviations.

Total recalls5since 2016
Last 12 months0reported
Class I00% of total
Ongoing1latest 23 Jul 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 4 80%Class III 1 20%

Why lisinopril and hydrochlorothiazide is recalled

Product types

By year

Ongoing lisinopril and hydrochlorothiazide recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsPackaging DefectsNationwide

All lisinopril and hydrochlorothiazide recalls, newest first

5 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg recalledLisinopril And HydrochlorothiazideCardinal HealthcareManufacturing (CGMP) DeviationsNationwide
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsOtherNationwide
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsOtherNationwide
DrugCLASS IIILisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsManufacturing (CGMP) DeviationsNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.